95 related articles for article (PubMed ID: 2406515)
1. Trisomy 14 in atypical chronic myeloid leukemia.
Mertens F; Johansson B; Heim S; Kristoffersson U; Mandahl N; Turesson I; Malm C; Othzén A; Bartram CR; Catovsky D
Leukemia; 1990 Feb; 4(2):117-20. PubMed ID: 2406515
[TBL] [Abstract][Full Text] [Related]
2. Molecular and cytogenetic characterization of a novel translocation t(4;22) involving the breakpoint cluster region and platelet-derived growth factor receptor-alpha genes in a patient with atypical chronic myeloid leukemia.
Safley AM; Sebastian S; Collins TS; Tirado CA; Stenzel TT; Gong JZ; Goodman BK
Genes Chromosomes Cancer; 2004 May; 40(1):44-50. PubMed ID: 15034867
[TBL] [Abstract][Full Text] [Related]
3. Molecular analysis of Philadelphia-positive childhood chronic myeloid leukemia.
Fioretos T; Heim S; Garwicz S; Ludvigsson J; Mitelman F
Leukemia; 1992 Jul; 6(7):723-5. PubMed ID: 1625493
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic spectrum of Philadelphia-chromosome negative leukemic disorders].
Kvasnicka HM
Pathologe; 2002 Nov; 23(6):448-56. PubMed ID: 12436298
[TBL] [Abstract][Full Text] [Related]
5. Clinical impact of breakpoint position within M-bcr in chronic myeloid leukemia.
Fioretos T; Nilsson PG; Aman P; Heim S; Kristoffersson U; Malm C; Simonsson B; Turesson I; Mitelman F
Leukemia; 1993 Aug; 7(8):1225-31. PubMed ID: 8350622
[TBL] [Abstract][Full Text] [Related]
6. ABL gene fuses BCR during t(20;22) results in Philadelphia-negative, but BCR/ABL-positive chronic myeloid leukemia.
Ito Y; Shimamoto T; Kuriyama Y; Nakajima A; Sumi M; Watanabe Y; Beppu H; Ohtsubo K; Ohyashiki K
Leukemia; 2002 May; 16(5):951-2. PubMed ID: 11986960
[No Abstract] [Full Text] [Related]
7. [Philadelphia chromosome-negative chronic myelogenous leukemia with trisomy 13].
Saigo K; Nakagawa T; Ryo R; Yamaguchi N
Rinsho Ketsueki; 1995 Nov; 36(11):1295-9. PubMed ID: 8691571
[TBL] [Abstract][Full Text] [Related]
8. p190 bcr-abl rearrangement: a secondary cytogenetic event in some chronic myeloid disorders?
Roumier C; Daudignon A; Soenen V; Dupriez B; Wetterwald M; Lai JL; Cosson A; Fenaux P; Preudhomme C
Haematologica; 1999 Dec; 84(12):1075-80. PubMed ID: 10586207
[TBL] [Abstract][Full Text] [Related]
9. The methylation status of the major breakpoint cluster region in human leukemia cells, including Philadelphia chromosome-positive cells, is linked to the lineage of hematopoietic cells.
Ohyashiki JH; Ohyashiki K; Kawakubo K; Tauchi T; Shimamoto T; Toyama K
Leukemia; 1993 Jun; 7(6):801-7. PubMed ID: 8501975
[TBL] [Abstract][Full Text] [Related]
10. [Acquisition of Philadelphia chromosome with bcr rearrangement concomitant with transformation of refractory anemia with excess of blasts with 8 trisomy into acute myelogenous leukemia].
Niikura H; Fujita K; Terada H; Haga A; Yamashina A
Rinsho Ketsueki; 1990 Mar; 31(3):335-40. PubMed ID: 2366338
[TBL] [Abstract][Full Text] [Related]
11. The relationship of bone marrow histology with the molecular pattern in chronic myeloid leukemia.
Vigorito AC; Lorand-Metze I; Chauffaile ML; Costa FF; Saad ST
Haematologia (Budap); 1998; 29(2):123-32. PubMed ID: 9728804
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the major breakpoint cluster region (M-bcr) in Philadelphia-positive CML.
Mills KI; Sproul AM; Burnett AK
Leukemia; 1993 May; 7(5):707-11. PubMed ID: 7683349
[TBL] [Abstract][Full Text] [Related]
13. Analysis of the clinical relevance of the breakpoint location within M-BCR and the type of chimeric mRNA in chronic myelogenous leukemia.
Rozman C; Urbano-Ispizua A; Cervantes F; Rozman M; Colomer D; Féliz P; Pujades A; Vives Corrons JL
Leukemia; 1995 Jun; 9(6):1104-7. PubMed ID: 7596178
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of variant translocations in chronic myelogenous leukemia.
Verma RS; Macera MJ; Benn P; Groffen J
Oncogene; 1989 Sep; 4(9):1145-8. PubMed ID: 2674857
[TBL] [Abstract][Full Text] [Related]
15. Frequencies of the breakpoint cluster region types of the BCR/ABL fusion gene in Mexican Mestizo patients with chronic myelogenous leukemia.
Ruiz-Argüelles GJ; Garcés-Eisele J; Reyes-Núñez V; Ruiz-Delgado GJ
Rev Invest Clin; 2004; 56(5):605-8. PubMed ID: 15776864
[TBL] [Abstract][Full Text] [Related]
16. Multiple restriction enzyme digests are required to rule out polymorphism in the molecular diagnosis of chronic myeloid leukemia.
Grossman A; Mathew A; O'Connell MP; Tiso P; Distenfeld A; Benn P
Leukemia; 1990 Jan; 4(1):63-4. PubMed ID: 1967323
[No Abstract] [Full Text] [Related]
17. Alternative BCR/ABL transcripts in chronic myeloid leukemia.
Zaccaria A; Tassinari A; Testoni N; Lauria F; Tura S; Algeri R; Guerrasio A; Rosso C; Saglio G
Blood; 1990 Oct; 76(8):1663-5. PubMed ID: 2207336
[No Abstract] [Full Text] [Related]
18. [The cellular and molecular-biological studies on Philadelphia chromosome-positive acute lymphocytic leukemia].
Kunieda Y
Hokkaido Igaku Zasshi; 1993 May; 68(3):337-49. PubMed ID: 8319933
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization of a variant Ph1 translocation t(9;22;11) (q34;q11;q13) in chronic myelogenous leukemia (CML) reveals the translocation of the 3'-part of BCR gene to the chromosome band 11q13.
Koduru PR; Goh JC; Pergolizzi RG; Lichtman SM; Broome JD
Oncogene; 1993 Dec; 8(12):3239-47. PubMed ID: 8247527
[TBL] [Abstract][Full Text] [Related]
20. [Molecular study of Ph1 chromosome negative chronic myelocytic leukemia].
Chen S
Zhonghua Yi Xue Za Zhi; 1991 Aug; 71(8):425-7, 30. PubMed ID: 1660759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
